PAR:CLARI

Clariane SE · PAR · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-07 18:28 UTC

Last close

n/aEUR

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

773.3xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
10.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
5.7%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed

Safety is the furthest below its sector's middle: 0.17 against 0.53 on the market's range.

Five bars, one line

lens 7 of 9

1.30x

0.03x

1.87x

1.22x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.30x
Its own average over 10 years, 4.10B.
Profit0.03x
Its own average over 9 years, 64.0M.
Free cash flow1.87x
Its own average over 10 years, 309.6M.
Debt1.22x
Its own average over 10 years, 6.38B.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at 0.03 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2016-12-31	100.0	100.0	100.0
2017-12-31	105.0	124.4	105.0
2018-12-31	111.9	93.8	106.1
2019-12-31	121.2	87.3	106.1
2020-12-31	126.5	30.0	116.6
2021-12-31	138.8	65.5	134.7
2022-12-31	148.9	16.8	132.8
2023-12-31	167.6	-80.2	160.5
2024-12-31	177.2	n/a	255.0
2025-12-31	178.1	1.2	391.9

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: EUR

How profit was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: EUR

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: EUR

Figures behind the shape

Growth

7.1%

faster is higher, placed against 1,434 companies as of 2026-11-06

Five-year revenue growth rate7.1%
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
Five-year EPS growth rate-59.8%
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
One-year change in net incomen/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed

Returns on capital

0.04%

higher is higher, placed against 5,089 companies as of 2026-11-06

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity0.04%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets0.01%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

8.1%

wider is higher, placed against 3,412 companies as of 2026-11-06

Gross margin8.1%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin5.6%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin0.03%
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin10.9%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

773.3x

cheaper is higher, placed against 4,362 companies as of 2026-11-06

Price to earnings773.3x
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
Price to book0.3x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.2x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

0.70

safer is higher, placed against 3,227 companies as of 2026-11-06

Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio0.70
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage0.9x
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score0.62
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

5.7%

more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06

Dividend yield5.7%
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
Payout ratio4372.3%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio8.3x
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.